相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of menopausal hormone therapy on COVID-19 severe outcomes in women-A population-based study of the US National COVID Cohort Collaborative (N3C) data
Yilin Yoshida et al.
MATURITAS (2023)
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women
J. Douxfils et al.
CLIMACTERIC (2023)
Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Charan Thej Reddy Vegivinti et al.
BMC INFECTIOUS DISEASES (2022)
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial
Karim Ali et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader et al.
LANCET INFECTIOUS DISEASES (2022)
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause
Celine Gerard et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
Laure Morimont et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
LANCET (2022)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Ivan O. Rosas et al.
INTENSIVE CARE MEDICINE (2021)
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
I. O. Rosas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study
Ricardo Costeira et al.
PLOS ONE (2021)
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial
Vincent C. Marconi et al.
LANCET RESPIRATORY MEDICINE (2021)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters
Jonathan Douxfils et al.
CONTRACEPTION (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evidence for treatment with estradiol for women with SARS-CoV-2 infection
Ute Seeland et al.
BMC MEDICINE (2020)
A minimal common outcome measure set for COVID-19 clinical research (vol 20, pg e192, 2020)
[Anonymous]
LANCET INFECTIOUS DISEASES (2020)
Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19
Selin Gencer et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis
Marie-Cecile Valera et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
The immune System Is a natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases
Deena Khan et al.
FRONTIERS IN IMMUNOLOGY (2016)